APR 20, 2018 9:29 AM PDT

Programming T Cells To Have Memory and Live for Decades

WRITTEN BY: Kara Marker

Memory T cells: where do they come from and how is their production controlled? Researchers from the Scripps Research Institute believe they have the answer, one which they hope to apply to improved treatment of chronic infections and cancer as well as enhancing the immune response to vaccines.

Scanning electron micrograph of a human T lymphocyte. Credit: NIAID

The key discovery was a transcription factor, a protein called Runx3 that facilitates the transition of T cells into memory T cells. This is opposed to the T cells becoming effector cells, which do not live past the resolution of the infection. Memory T cells can live for many years.

Understanding and manipulating this process could help scientists develop drugs that boost the immune response to vaccines. In other cases of chronic disease, T cells need a boost to continue fighting a prolonged attack on the body, and Runx3 could be the perfect tool to get the job done.

"There are instances such as chronic infection and tumors where the T cells differentiate in an aberrant way that shortens their life span and decreases their function," explained Matthew Pipkin, PhD. "Because our study found that Runx3 is one of the earliest players during an immune response, manipulating it might be an avenue to basically turn back the clock and reprogram dysfunctional T cells into a format that is conducive to them developing into genuine memory cells that are protective.

Pipkin and his team tinkered with Rnx3 expression to see what would happen in the cell, first suppressing it. Any cells lost would be a direct result of lacking Rnx3. So when memory T cell levels dwindled in the absence of Rnx3, researchers could confirm the relationship between the two entities. Additionally, cells with increased expression of Rnx3 produce more memory T cells.

Interestingly, these Rnx3-boosted cells were also more efficient at producing more and more memory T cells when chronically exposed to a virus - lymphocytic choriomeningitis virus (LCMV) - and bacteria - Listeria monocytogenes (compared to cells with a normal amount of Rnx3).

How does it work? Researchers observed that Runx3 suppresses another transcription factor to reduce the number of effector T cells produced, instead pushing cells to become memory T cells. Additionally, Runx3 jumps into action to do so as soon as a few hours after the initial infection.

"We know that Runx3 is working with a number of additional transcription factors and chromatin regulatory proteins," Pipkin says. "So, we are currently trying to identify them and determine how they collaborate with Runx3 to turn on and off different regions of the genome to promote memory development."

The present study was published in the journal Immunity.

Sources: Scripps Research Institute, National Center for Biotechnology Information

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 10, 2021
Drug Discovery & Development
Black Men Respond Best to Immunotherapy for Prostate Cancer
FEB 10, 2021
Black Men Respond Best to Immunotherapy for Prostate Cancer
Researchers from Northwestern University have found that Black men and men of African ancestry respond better than men f ...
MAR 07, 2021
Genetics & Genomics
Tuberculosis Influenced the Human Genome
MAR 07, 2021
Tuberculosis Influenced the Human Genome
Throughout human history, our species has come into contact with both harmless and infectious microbes that have changed ...
APR 22, 2021
Immunology
Healthy, Young People Are Getting Reinfected With COVID
APR 22, 2021
Healthy, Young People Are Getting Reinfected With COVID
If you’re young and healthy and you’ve had COVID, your body will produce protective antibodies that guard yo ...
MAY 04, 2021
Immunology
One Vaccine to Rule Them All
MAY 04, 2021
One Vaccine to Rule Them All
There are currently five variants of concern in the U.S., genetically distinct forms of the COVID-causing coronavirus th ...
MAY 19, 2021
Drug Discovery & Development
Combination Immunotherapy Shows Promise in Treating HIV
MAY 19, 2021
Combination Immunotherapy Shows Promise in Treating HIV
  Researchers have found that a new combination immunotherapy, alongside antiretroviral therapy (ART), is effective ...
JUN 07, 2021
Health & Medicine
Higher Incidence of Breast Cancer in Polluted Urban Areas
JUN 07, 2021
Higher Incidence of Breast Cancer in Polluted Urban Areas
A Taiwanese study looked at the incidence of breast cancer in areas of Taiwan with varying levels of air pollutants. Air ...
Loading Comments...